BALYASNY ASSET MANAGEMENT L.P. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$13,436,500
+177.0%
350,000
+36.9%
0.03%
+145.5%
Q2 2023$4,850,193
-27.3%
255,677
-32.0%
0.01%
-38.9%
Q4 2022$6,670,006
+678.3%
375,775
+144.8%
0.02%
+500.0%
Q3 2022$857,000
+958.0%
153,503
+950.2%
0.00%
Q1 2022$81,000
-97.1%
14,616
-75.6%
0.00%
-100.0%
Q4 2020$2,770,00059,9740.02%
Other shareholders
IMMUNOVANT INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,000,200$26,072,0005.92%
MANGROVE PARTNERS IM, LLC 1,139,900$9,906,0000.89%
Eventide Asset Management 4,950,000$43,016,0000.57%
Ghost Tree Capital, LLC 200,000$1,738,0000.51%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,221,0000.47%
FRAZIER MANAGEMENT LLC 585,759$5,090,0000.41%
MANGROVE PARTNERS IM, LLC 500,000$4,345,0000.39%
EcoR1 Capital, LLC 1,140,819$9,914,0000.34%
BCK CAPITAL MANAGEMENT LP 53,459$465,0000.28%
PLATINUM INVESTMENT MANAGEMENT LTD 555,065$4,824,0000.14%
View complete list of IMMUNOVANT INC shareholders